Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106


Nerve Growth Factor Receptors and Signaling in Breast Cancer

Volume:4   Issue:6
Pp: 463-470
Laurent Dolle, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe and Hubert Hondermarck
DOI: 10.2174/1568009043332853

Order Reprints Order Eprints

Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

Volume:4   Issue:6
Pp: 471-482
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
DOI: 10.2174/1568009043332835

Order Reprints Order Eprints

The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma

Volume:4   Issue:6
Pp: 511-520
Noriyuki Takai, Tami Ueda, Masakazu Nishida, Kaei Nasu and Isao Miyakawa
DOI: 10.2174/1568009043332871

Order Reprints Order Eprints

Mammaglobin-Based Strategies for Treatment of Breast Cancer

Volume:4   Issue:6
Pp: 531-542
Peter S. Goedegebuure, Mark A. Watson, Carsten T. Viehl and Timothy P. Fleming
DOI: 10.2174/1568009043332862

Order Reprints Order Eprints